shRNA Citations
OriGene products have been used extensively by scientists worldwide to improve their research efficiency. For your reference, we have collected a representation of citations for selected OriGene products and posted them at this site.
Search citations by gene symbols or target names
Here are some of the recent papers making use of OriGene products by fellow researchers.
| Target | Research Paper | Journal | Product | SKU |
|---|---|---|---|---|
| Lcn2 | Mutant p53 Together with TGFß Signaling Influence Organ-Specific Hematogenous Colonization Patterns of Pancreatic Cancer | Clin. Cancer Res., 2016 Sep | shRNA | MR226233 |
| LCN2 | Lipocalin 2 Enhances Migration and Resistance against Cisplatin in Endometrial Carcinoma Cells | PLoS ONE, 2016 May | shRNA | TG311777 |
| LCN2 | Lipocalin 2 attenuates iron-related oxidative stress and prolongs the survival of ovarian clear cell carcinoma cells by up-regulating the CD44 variant | Free radical Research, 2016 Feb | shRNA | TG311777 |
| LDHA | Tumor-Derived Lactic Acid Contributes to the Paucity of Intratumoral ILC2s | Cell Rep, 2020 Feb | shRNA | TG515372 |
| Leap2 | Liver-expressed antimicrobial peptide 2 elevation contributes to age-associated cognitive decline | JCI Insight, 2023 May | shRNA | TR519691 |
| LEF1 | MicroRNAs Regulate Pituitary Development, and MicroRNA 26b Specifically Targets Lymphoid Enhancer Factor 1 (Lef-1), Which Modulates Pituitary Transcription Factor 1 (Pit-1) Expression | J. Biol. Chem., Nov 2010; 285: 34718 - 34728, 2010 Nov | shRNA | TR712526 |
| LEO1 | A role for the RNA pol II–associated PAF complex in AID-induced immune diversification | J. Exp. Med., Oct 2012; 209: 2099 - 2111., 2012 Oct | shRNA | TG303551 |
| LEO1 | A role for the RNA pol II–associated PAF complex in AID-induced immune diversification | J. Exp. Med., Sep 2012; 10.1084/jem.20112145., 2012 Sep | shRNA | TR303551 |
| LETM1 | LETM1-mediated K+ and Na+ homeostasis regulates mitochondrial Ca2+ efflux | Frontiers in Physiology, 2017 Nov | shRNA | TR311758 |
| LGR5 | FOXO1 reduces tumorsphere formation capacity and has crosstalk with LGR5 signaling in gastric cancer cells | Biochem. Biophys. Res. Commun., 2017 Nov | shRNA | TF311747 |
| LIMK1 | Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects | Nature Medicine 18, 1087-1094 doi:10.1038/nm.2834, 2012 Jun | shRNA | TR320403 |
| LINC00261 | LINC00261 is an epigenetically-regulated tumor suppressor that is essential for activation of the DNA damage response | Cancer Res., 2019 Feb | shRNA | HC137604 |
| LINC00504 | The LINC00504/Mir-4739/KLK4 Axis Facilitates Cell Proliferation and Suppresses Cell Apoptosis Through Triggering The Wnt/Β-Catenin Pathway In Triple-Negative Breast Cancer Cells | Research Square, 2020 Dec | shRNA | TR318094 |
| LMBRD1 | LMBD1 protein participates in cell mitosis by regulating microtubule assembly | The Biochemical journal, 2021 Jun | shRNA | TF303512 |
| LMNA | Promoter hypermethylation as a mechanism for Lamin A/C silencing in a subset of neuroblastoma cells | PLoS ONE, 2017 Apr | shRNA | TG303510 |
| LMO1 | LMO1 functions as an oncogene by regulating TTK expression and correlates with neuroendocrine differentiation of lung cancer | Oncotarget, 2018 Jul | shRNA | TG311708 |
| LNP1 | Lunapark Is a Component of a Ubiquitin Ligase Complex Localized to the Endoplasmic Reticulum Three-way Junctions | J. Biol. Chem., 2016 Jul | shRNA | TR320968 |
| LOC298795 | Amifostine alleviates radiation-induced lethal small bowel damage via promotion of 14-3-3σ-mediated nuclear p53 accumulation | Oncotarget, 2014 Oct | shRNA | TL702077 |
| LOXL2 | Lysyl oxidase-like protein-2 regulates sprouting angiogenesis and type IV collagen assembly in the endothelial basement membrane | Blood, Oct 2011; 118: 3979 - 3989., 2011 Oct | shRNA | TR311699 |
| LPAR1 | High Glucose Induces VEGF-C Expression via the LPA1/3-Akt-ROS-LEDGF Signaling Axis in Human Prostate Cancer PC-3 Cells | Cell. Physiol. Biochem., 2018 Oct | shRNA | TR313300 |
| LPAR1 | Lysophosphatidic acid signaling via LPA1 and LPA3 regulates cellular functions during tumor progression in pancreatic cancer cells | Experimental Cell Research, 2017 Feb | shRNA | TR313300 |
| LPAR1 | Different induction of LPA receptors by chemical liver carcinogens regulates cellular functions of liver epithelial WB-F344 cells | Mol. Carcinog., 2015 Sep | shRNA | TF712271 |
| Lpar1 | LPA signaling through LPA receptors regulates cellular functions of endothelial cells treated with anticancer drugs | Mol. Cell. Biochem., 2015 Jun | shRNA | TG509224 |
| LPAR2 | Roles of endothelial cells in the regulation of cell motility via lysophosphatidic acid receptor-2 (LPA2) and LPA3 in osteosarcoma cells | Experimental and molecular pathology, 2020 Dec | shRNA | TG313298 |
| LPAR2 | Different effects of lysophosphatidic acid receptor-2 (LPA2) and LPA5 on the regulation of chemoresistance in colon cancer cells | J. Recept. Signal Transduct. Res., 2020 Jul | shRNA | TG313298 |
| LPAR2 | Lysophosphatidic acid receptor-2 (LPA2)-mediated signaling enhances chemoresistance in melanoma cells treated with anticancer drugs | Mol. Cell. Biochem., 2020 Apr | shRNA | TG313298 |
| LPAR2 | Involvement of LPA signaling via LPA receptor-2 in the promotion of malignant properties in osteosarcoma cells | Exp. Cell Res., 2018 May | shRNA | TR313298 |
| LPAR2 | Enhanced cellular functions through induction of LPA2 by cisplatin in fibrosarcoma HT1080 cells | Mol. Cell. Biochem, 2017 Feb | shRNA | TR313298 |
| Lpar2 | LPA signaling through LPA receptors regulates cellular functions of endothelial cells treated with anticancer drugs | Mol. Cell. Biochem., 2015 Jun | shRNA | TG502984 |
| Lpar3 | Effects of lysophosphatidic acid (LPA) receptor-2 (LPA2) and LPA3 on the regulation of chemoresistance to anticancer drug in lung cancer cells | Cell. Signal., 2020 Feb | shRNA | TG517410 |
| LPAR3 | High Glucose Induces VEGF-C Expression via the LPA1/3-Akt-ROS-LEDGF Signaling Axis in Human Prostate Cancer PC-3 Cells | Cell. Physiol. Biochem., 2018 Oct | shRNA | TR313295 |
| LPAR3 | Lysophosphatidic acid signaling via LPA1 and LPA3 regulates cellular functions during tumor progression in pancreatic cancer cells | Experimental Cell Research, 2017 Feb | shRNA | TR313295 |
| LPAR3 | Different induction of LPA receptors by chemical liver carcinogens regulates cellular functions of liver epithelial WB-F344 cells | Mol. Carcinog., 2015 Sep | shRNA | TG710942 |
| Lpar3 | LPA signaling through LPA receptors regulates cellular functions of endothelial cells treated with anticancer drugs | Mol. Cell. Biochem., 2015 Jun | shRNA | TG517410 |
| LPAR4 | Lysophosphatidic acid (LPA) signaling via LPA4 and LPA6 negatively regulates cell motile activities of colon cancer cells | Biochem. Biophys. Res. Commun, 2016 Dec | shRNA | TR312652 |
| LPAR4 | Diverse effects of LPA4, LPA5 and LPA6 on the activation of tumor progression in pancreatic cancer cells | Biochem. Biophys. Res. Commun., 2015 Apr | shRNA | TF312652 |
| LPAR5 | Different effects of lysophosphatidic acid receptor-2 (LPA2) and LPA5 on the regulation of chemoresistance in colon cancer cells | J. Recept. Signal Transduct. Res., 2020 Jul | shRNA | TG304222 |
| LPAR5 | LPA5-mediated signaling induced by endothelial cells and anticancer drug regulates cellular functions of osteosarcoma cells | Experimental Cell Research, 2020 Jan | shRNA | TG304222 |
| LPAR5 | Modulation of chemoresistance by lysophosphatidic acid (LPA) signaling through LPA5 in melanoma cells treated with anticancer drugs | Biochem. Biophys. Res. Commun., 2019 Jul | shRNA | TG304222 |
| LPAR5 | Diverse effects of LPA4, LPA5 and LPA6 on the activation of tumor progression in pancreatic cancer cells | Biochem. Biophys. Res. Commun., 2015 Apr | shRNA | TG304222 |
| LPAR5 | Inhibitory effects of lysophosphatidic acid receptor-5 on cellular functions of sarcoma cells | Growth Factors, 2014 May | shRNA | TG304222 |
| LPAR5 | Lysophosphatidic acid receptor-5 negatively regulates cell motile and invasive activities of human sarcoma cell lines | Mol. Cell. Biochem. March 2014, 2014 Mar | shRNA | TG304222 |
| Lpar5 | Lysophosphatidic acid receptor-5 negatively regulates cellular responses in mouse fibroblast 3T3 cells | Biochem. Biophys. Res. Commun., 2014 Mar | shRNA | TG304222 |
| LPAR6 | Lysophosphatidic acid (LPA) signaling via LPA4 and LPA6 negatively regulates cell motile activities of colon cancer cells | Biochem. Biophys. Res. Commun, 2016 Dec | shRNA | TR310642 |
| LPAR6 | Diverse effects of LPA4, LPA5 and LPA6 on the activation of tumor progression in pancreatic cancer cells | Biochem. Biophys. Res. Commun., 2015 Apr | shRNA | TF310642 |
| Lpcat1 | Acyl-CoA:Lysophosphatidylcholine Acyltransferase I (Lpcat1) Catalyzes Histone Protein O -Palmitoylation to Regulate mRNA Synthesis | The Journal of Biological Chemistry, 2011 Aug | shRNA | TL704171 |
| LRP10 | Anti-Argonaute RIP-Chip shows that miRNA transfections alter global patterns of mRNA recruitment to microribonucleoprotein complexes | RNA, 2010 Feb | shRNA | TL311681 |
| LRP6 | Unveiling the Roles of Low-Density Lipoprotein Receptor-Related Protein 6 in Intestinal Homeostasis, Regeneration and Oncogenesis | Research Square, 2021 Feb | shRNA | TG509944 |
| LRP6 | RASSF10 suppresses lung cancer proliferation and invasion by decreasing the level of phosphorylated LRP6 | Mol. Carcinog., 2019 Mar | shRNA | TG311676 |
| Lrrfip1 | The cytosolic nucleic acid sensor LRRFIP1 mediates the production of type I interferon via a beta-catenin-dependent pathway. | Nature immunology, 2010 Jun | shRNA | TL514790 |
Germany
Japan
United Kingdom
China